Eledon Pharmaceuticals, Inc.ELDNNASDAQ
LOADING
|||
Analyst Sentiment
Analysts lean bullish — 100% recommend buying.
Consensus Rating
Buy
4 analysts·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
4100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Analysts see significant upside — consensus target 298% higher.
Bear Case
$9.00
+298%
Consensus
$9.00
+298%
Bull Case
$9.00
+298%
Price Range4 analysts
Low
Consensus
High
$9.00
$9.00
Current Target
Current Price
$2.26
Upside to Target
$6.74
Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
2026E$-0.91(4 analysts)
Actual
Estimate
Range (Low–High)
Forward Growth Estimates (YoY)
FY2027
Rev—
EPS—
FY2028
Rev—
EPS—
FY2029
Rev+339.32%
EPS—
Earnings Surprises
Beat rate:67%(8/12 quarters)
Avg surprise:+5.7%
Beat
Miss
Inline
Estimate